Dyne Therapeutics DYN
NASDAQ DYN
$15.62 -0.15 (-0.95%)
At close: Oct 23, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Cash & Current Investments (2019 - 2026)

Updated

Dyne Therapeutics (DYN) reported Cash & Current Investments of $898.48 million for Q2 2026, up 31.4% from $683.93 million a year earlier but down 7.6% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Dyne Therapeutics posted Cash & Current Investments of $1.11 billion, up 72.9% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 26.3% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $642.27 million in FY2024 (+421.7%), $123.1 million in FY2023 (-51.9%), $256.01 million in FY2022 (-32.0%) and $376.57 million in FY2021 (+9.1%).
  • Five-year quarterly Cash & Current Investments spans a low of $123.1 million in Q4 2023 and a high of $1.11 billion in Q4 2025.
  • Year over year, Cash & Current Investments has now increased in each of the last four quarters, with growth averaging 121.8% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q4 2024 (growth of 421.7%); the low point was Q4 2023 (a decline of 51.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $972.16 million (Q1 2026), $1.11 billion (Q4 2025) and $791.89 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Dyne Therapeutics 2.59 Bn -1.18 Bn - 898.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 898.48 Mn
Mar 31, 2026 972.16 Mn
Dec 31, 2025 1.11 Bn
Sep 30, 2025 791.89 Mn
Jun 30, 2025 683.93 Mn
Mar 31, 2025 677.49 Mn
Dec 31, 2024 642.27 Mn
Sep 30, 2024 723.67 Mn
Jun 30, 2024 778.84 Mn
Mar 31, 2024 453.55 Mn
Dec 31, 2023 123.10 Mn
Sep 30, 2023 157.82 Mn
Jun 30, 2023 207.73 Mn
Mar 31, 2023 238.21 Mn
Dec 31, 2022 256.01 Mn
Sep 30, 2022 248.14 Mn
Jun 30, 2022 291.84 Mn
Mar 31, 2022 323.15 Mn
Dec 31, 2021 376.57 Mn
Sep 30, 2021 407.52 Mn
API Access

Dyne Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DYN&period=max&api_key=YOUR_API_KEY